Somewhat Positive Press Coverage Somewhat Unlikely to Affect Cognex (CGNX) Stock Price

Headlines about Cognex (NASDAQ:CGNX) have trended somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cognex earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned media stories about the scientific and technical instruments company an impact score of 46.6802612798242 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

A number of equities research analysts recently issued reports on the company. Robert W. Baird increased their price target on Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 31st. BidaskClub downgraded Cognex from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. ValuEngine downgraded Cognex from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Zacks Investment Research raised Cognex from a “hold” rating to a “buy” rating and set a $69.00 price target on the stock in a research report on Wednesday, November 1st. Finally, Canaccord Genuity increased their price target on Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research report on Tuesday, October 31st. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $60.17.

Cognex (NASDAQ CGNX) traded up $0.35 during midday trading on Thursday, reaching $61.43. The company’s stock had a trading volume of 855,900 shares, compared to its average volume of 1,594,868. Cognex has a 12-month low of $31.18 and a 12-month high of $72.99. The company has a market capitalization of $10,640.00, a PE ratio of 45.17 and a beta of 1.50.

Cognex (NASDAQ:CGNX) last released its earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The firm had revenue of $259.74 million during the quarter, compared to analysts’ expectations of $255.95 million. During the same period in the prior year, the company earned $0.31 earnings per share. The company’s quarterly revenue was up 75.6% on a year-over-year basis. research analysts predict that Cognex will post 1.39 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 1st. Shareholders of record on Friday, November 17th were paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend was Thursday, November 16th. Cognex’s payout ratio is presently 13.24%.

In other Cognex news, CEO Robert Willett sold 100,000 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $127.19, for a total transaction of $12,719,000.00. Following the completion of the sale, the chief executive officer now directly owns 100,000 shares in the company, valued at $12,719,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick Alias sold 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $143.54, for a total value of $717,700.00. The disclosure for this sale can be found here. Insiders have sold 143,750 shares of company stock valued at $18,540,975 over the last 90 days. Corporate insiders own 5.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.com-unik.info/2017/12/28/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-cognex-cgnx-stock-price.html.

About Cognex

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit